Pharmacy Services
Methotrexate Injection From Bedford Recalled Due to Ethylene Glycol Content
December 15, 2005
Bedford Laboratories voluntarily recalled 1 lot of preservative-free methotrexate injection in 1 gram vials (NDC 55390-0143-01, lot@ 859142, expiry 09/2007). The active drug substance used to manufacture this product contained small amounts of ethylene glycol. Additional information is available at the following link:
- University of Utah Methotrexate Shortage Memo (internal):
http://intranet.uuhsc.utah.edu/pharmacy/shortages/methotrexate.html - MedWatch Alert:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm151744.htm
Updated
December 15, 2005; University of Utah, Drug Information Service. Copyright 2009, Drug Information Service, University of Utah, Salt Lake City, UT.
Social Media
Copyright © 2013 University of Utah Health Care